Biotech, Biologics, and Compliance
Navigating You Through the FDA Regulatory Process
Top Rated Nationwide
Biotechnology Law Team
With a healthcare and life science background, TALG represents publicly traded and smaller market Biologics and Biotech firms, from coast to coast. TALG merges law with science to counsel clients in a wide array of biotech areas including FDA compliance issues, capital markets, corporate governance, and product development issues. Proud to call itself an “academic” law firm, TALG attorneys are skilled professionals with science backgrounds in Genetics & Genomics, Biotechnology, Enterprise & Entrepreneurship. With over 15 years of dedicated and exceptional service to our clients, our team possesses the know-how and is prepared to assist you with all of your biotech legal needs. We look forward to providing you with quality, effective, and thorough representation.
Biotech, Biologics, and Compliance Specialties
Biotech, Biologics, and Compliance
We have a unique understanding of the needs of embryonic biotechnology firms with promising technology and the need for access to capital markets, while efficiently navigating the complex FDA compliance process. We have represented larger biotechnology and publicly traded biologics companies for over 10 years.
Please reference our Biotech Bulletin for additional information about biotechnology and current events in the field of biotechnology.
Biotech, Biologics, and Compliance Attorneys
We Understand the Biotech Industry
TALG Law is dedicated to pursuing our clients’ best interests. Whether it be working with them through company governance issues or obtaining regulatory approvals, we pride ourselves in providing zealous, thorough, and efficient advocacy from start to finish.
As zealous advocates, we use our arsenal of legal knowledge, combined with strategic thinking and planning, to achieve results.
Our work is both thorough and thoroughly communicated. We recognize that each case is different and deserves quality preparation. Additionally, we keep clients well apprised, so they know what is happening with their case, what our strategies are, and what to expect during each step of the process.
We recognize that there is not a one-size-fits-all approach to biotech law. Our team understands the science behind our clients’ products, processes and properties. We understand emerging and established technologies pertaining to biotechnology industries.
Our results speak for themselves, and our reward for those results are lifelong relationships with our clients.
From Our Clients
Recent Biotech, Biologics, and Compliance News
The FDA announced the new Center for Clinical Trial Innovation to serve as a central hub to support innovative approaches to clinical trials.
Clinical trials are essential for healthcare decisions. Poorly designed trials risk the safety of participants and produce unreliable data.
The FDA’s Center for Drug Evaluation and Research (CDER) issued a discussion paper on the role of Artificial Intelligence.
Biotech and life-science companies are often in need of appropriate capital to execute the company’s mission.